Oral Dydrogesterone vs. Vaginal Micronized Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer

Last updated: October 6, 2020
Sponsor: Wolfson Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT03832699
0013-19-WOMC
  • Ages 18-39
  • Female
  • Accepts Healthy Volunteers

Study Summary

The current trial is intended to assess the efficacy of oral versus vaginal progesterone for luteal support in frozen IVF cycles.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Ages 18-39

  • Modified natural cycle (induction of ovulation with HCG)

  • Consent to participation

Exclusion

Exclusion Criteria:

  • None

Study Design

Total Participants: 100
Study Start date:
March 01, 2019
Estimated Completion Date:
October 31, 2021

Study Description

Progesteron is used for luteal phase support in IVF cycles. Progesterone can be administered vaginally and orally. Duphaston is an oral progesterone drug, which has recentlly been proven effective in fresh cycle IVF. Yet, less is known regarding its efficacy in frozen cycle IVF. Thus, the objective of our trial is to compare the efficacy of vaginal and oral progesterone in frozen IVF cycles.

Connect with a study center

  • Edith Wolfson Medical Center

    Holon, 5822012
    Israel

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.